Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 22 (August 1), 2005: pp. 5263-5264
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.01.2294

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kissane, D. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kissane, D. W.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

In Reply:

David W. Kissane

Memorial Sloan-Kettering Cancer Center, New York, NY

Cunningham and Edwards make valid points about specific subgroups of patients that may be helped. More targeted interventions to patients with particular needs are desirable.

Solid research data exist stating that depressed patients have lower rates of survival,1 but mechanisms are not yet elucidated. An attractive hypothesis is nonadherence to effective anticancer treatments by patients who have "given up," become demoralized, or use primitive denial as their coping response. In addition to standard treatment with antidepressant medication, we have found evidence that group therapy has the ability to not only treat DSM-IV depressive disorders in women with advanced breast cancer, but also prevent the onset of new cases (submitted, Grabsch et al, 2005). We are challenged clinically to find reliable methods of recognizing these depressed and otherwise "at risk" patients with screening methods showing considerable promise.2

More research is called for to explore interventions that promote adherence to cancer treatments such as chemotherapy. Such targeted approaches will enhance quality of life while aligning psycho-oncologists in a useful partnership of complementary care with oncologists.

The absence of a substantial survival benefit emerging from the more recent trials of group therapy may give peace of mind to patients less comfortable in the group setting, who may have felt pressure to incorporate such a modality of treatment in their care plan. On the other hand, Pam Goodwin is a great advocate for the many psychosocial and quality-of-life benefits that can be achieved from these group interventions.

Author's Disclosures of Potential Conflicts of Interest

The author indicated no potential conflicts of interest.

REFERENCES

1. Watson M, Haviland JS, Greer S, et al: Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet 354:1331-1336, 1999[CrossRef][Medline]

2. McLachlan SA, Allenby A, Matthew J, et al: Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol 19:4117-4125, 2001[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Correspondence

  • Possible Effects of Psychological Therapy on Survival Duration in Cancer Patients
    Alastair J. Cunningham and Claire V.I. Edmonds
    JCO 2005 23: 5263 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kissane, D. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kissane, D. W.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online